+34 935532642mhospedales@ticsalut.catFollow usm-Resist YouTube
m-Resist Vision
In the European Union, around 5 million people suffer from psychotic disorders, being schizophrenia one of the most widely-known. Around 30-50% patients are considered treatment-resistant and present persistent symptoms, requiring long periods of hospital care and being at greater risk of mortality and multi morbidity. During the 3 years of the project, a model of analysis will be implemented, in order to move forward in understanding resistant schizophrenia.
Besides, project activities will help to predict patient’s behaviour and to allow the establishment of a reaction alert system, as well as to draw up protocols and recommendations to give doctors support in the clinical decisions. By linking data mining tools with a high-level predictive model, m-RESIST will bring forth a new technical focus for health treatments, which will allow the behaviour patterns found in many patient data to be analysed in order to identify the risks and shortcomings of the treatments.